Back

SGLT2 inhibitor initiation in patients hospitalized for acute heart failure: does it still matter when patients are strictly followed after discharge?

22 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 4 Pharmacotherapy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Beatriz Valente Silva

CHULN and Faculty of medicine of the University of Lisbon, Lisbon (Portugal)

37 More presentations in this session

Presentation thumbnail
Quadruple therapy with ARNI vs quadruple therapy with ACEI on cardiovascular outcomes for heart failure with reduced ejection fraction: a network meta-analysis
Doctor J. Diaz Acevedo (Dalton, US)
Abstract Slides
Presentation thumbnail
Position and cardiorenal mechanisms of uromodulin in heart failure
Doctor L. Emmens (Groningen, NL)
Abstract Slides
Presentation thumbnail
Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)
Doctor E. Barge Caballero (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Hepatic T1-time is a strong and independent predictor of cardiovascular outcome in all-comers referred for cardiac magnetic resonance imaging
Doctor K. Mascherbauer (Vienna, AT)
Abstract Slides
Presentation thumbnail
Virtual management of HF outpatient during COVID-19 pandemic period: a comparison with traditional follow up
Doctor S. Prosperi (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 4

The Event

Event poster

Heart Failure 2022

22 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources